Page last updated: 2024-10-30

mazindol and Dementia Praecox

mazindol has been researched along with Dementia Praecox in 5 studies

Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.

Research Excerpts

ExcerptRelevanceReference
"Both Parkinson's disease and progressive supranuclear palsy populations were characterized by a marked loss of [3H]mazindol binding sites in the neostriatum (about 75%) and in the nucleus accumbens (about 65%)."1.28Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol. ( Alvarez, FJ; Chinaglia, G; Palacios, JM; Probst, A, 1992)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carpenter, WT1
Breier, A1
Buchanan, RW1
Kirkpatrick, B1
Shepard, P1
Weiner, E1
McMahon, LR1
Cunningham, KA1
Chinaglia, G1
Alvarez, FJ1
Probst, A1
Palacios, JM1
Dworkin, RH1
Opler, LA1
Seibyl, JP1
Brenner, L1
Krystal, JH1
Johnson, R1
Charney, DS1

Trials

1 trial available for mazindol and Dementia Praecox

ArticleYear
Mazindol treatment of negative symptoms.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2000, Volume: 23, Issue:4

    Topics: Adult; Analysis of Variance; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Fe

2000

Other Studies

4 other studies available for mazindol and Dementia Praecox

ArticleYear
Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2001, Volume: 24, Issue:3

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Biogenic Monoamines; Catecholamines; Depression; D

2001
Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol.
    Neuroscience, 1992, Volume: 49, Issue:2

    Topics: Aged; Aged, 80 and over; Autoradiography; Basal Ganglia; Carrier Proteins; Corpus Striatum; Dopamine

1992
Simple schizophrenia, negative symptoms, and prefrontal hypodopaminergia.
    The American journal of psychiatry, 1992, Volume: 149, Issue:9

    Topics: Dopamine; Frontal Lobe; Humans; Levodopa; Mazindol; Schizophrenia; Schizophrenic Psychology

1992
Mazindol and cocaine addiction in schizophrenia.
    Biological psychiatry, 1992, Jun-01, Volume: 31, Issue:11

    Topics: Adult; Cocaine; Humans; Male; Mazindol; Schizophrenia; Substance-Related Disorders

1992